Savage Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAVAGE LABS
SAVAGE LABS has thirty-four approved drugs.
Summary for Savage Labs
| US Patents: | 0 |
| Tradenames: | 20 |
| Ingredients: | 17 |
| NDAs: | 34 |
Drugs and US Patents for Savage Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | K-LEASE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 072427-001 | Mar 28, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Savage Labs | TRYSUL | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) | CREAM;VAGINAL | 087887-001 | Jul 23, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Savage Labs | ALPHATREX | betamethasone dipropionate | LOTION;TOPICAL | 070273-001 | Aug 12, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Savage Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | 3,745,212 | ⤷ Start Trial |
| Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | 3,801,562 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
